Skip to main content

Advertisement

SpringerLink
Log in

XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro

  • Research Article
  • Published:
Clinical and Translational Oncology Aims and scope Submit manuscript

Abstract

Background

Bladder cancer is the second most common urological malignancy around the world and is by far the most frequent urological malignancy in China. Embelin is an active compound identified as a novel X-chromosome-linked IAP (XIAP) inhibitor from the Embelia ribes that exhibits various medicinal effects including anti-inflammatory and anti-cancer activities. However, therapeutic effect of Embelin to human bladder cancer is not yet determined.

Methods

We evaluated the sensitizing potential of Embelin on inhibiting cell growth and migration of bladder cancer cell line by CCK8, Transwell, and Western Blot, and explored its related mechanism. We performed IHC staining of XIAP in 35 bladder cancer tissues and corresponding adjacent non-neoplastic tissues.

Results

XIAP was significantly upregulated in bladder cancer cases. When the concentration of Embelin was used respectively at 5, 10, 20, 25, and 35 µmol/l, the survival of both T24 and 5637 cells decreased in a dose-/time-dependent manner. Our study confirmed that with the increase of concentration of Embelin, the expression levels of PI3K and p-Akt decreased significantly which further confirmed that Embelin inhibits cell growth by inducing apoptosis via PI3K/Akt pathway.

Conclusions

Embelin may be developed into a novel and potential chemotherapeutic drug for bladder cancer.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin. 2014;64(1):9–29.

    Article  PubMed  Google Scholar 

  2. Witjes JA, Comperat E, Cowan NC, De Santis M, Gakis G, Lebret T, et al. EAU guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2013 guidelines. Eur Urol. 2014;65(4):778–92.

    Article  PubMed  Google Scholar 

  3. Von der Maase H, Sengelov L, Roberts JT, Ricci S, Dogliotti L, Oliver T, et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J Clin Oncol. 2005;23(21):4602–8.

    Article  PubMed  Google Scholar 

  4. Shirodkar SP, Lokeshwar VB. Potential new urinary markers in the early detection of bladder cancer. Curr Opin Urol. 2009;19(5):488–93.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Garcia-Fernandez M, Kissel H, Brown S, Gorenc T, Schile AJ, Rafii S, et al. Sept4/arts is required for stem cell apoptosis and tumor suppression. Genes Dev. 2010;24(20):2282–93.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  6. Debatin KM. Apoptosis pathways in cancer and cancer therapy. Cancer Immunol Immunother. 2004;53(3):153–9.

    Article  PubMed  Google Scholar 

  7. Joshi R, Kamat JP, Mukherjee T. Free radical scavenging reactions and antioxidant activity of embelin: biochemical and pulse radiolytic studies. Chem Biol Interact. 2007;167(2):125–34.

    Article  CAS  PubMed  Google Scholar 

  8. Chitra M, Devi CS, Sukumar E. Antibacterial activity of embelin. Fitoterapia. 2003;74(4):401–3.

    Article  CAS  PubMed  Google Scholar 

  9. Yang T, Lan J, Huang Q, Chen X, Sun X, Liu X, et al. Embelin sensitizes acute myeloid leukemia cells to TRAIL through XIAP inhibition and NF-κB inactivation. Cell Biochem Biophys. 2015;71(1):291–7.

    Article  CAS  PubMed  Google Scholar 

  10. Waerner T, Alacakaptan M, Tamir I, Oberauer R, Gal A, Brabletz T, et al. ILEI: a cytokine essential for EMT, tumor formation, and late events in metastasis in epithelial cells. Cancer Cell. 2006;10(3):227–39.

    Article  CAS  PubMed  Google Scholar 

  11. Beug ST, LaCasse EC, Korneluk RG. Smac mimetics combined with innate immune stimuli create the perfect cytokine storm to kill tumor cells. Oncoimmunology. 2014;3:e28541.

    Article  PubMed Central  PubMed  Google Scholar 

  12. Yabal M, Muller N, Adler H, Knies N, Gross CJ, Damgaard RB, et al. Xiap restricts tnf- and rip3-dependent cell death and inflammasome activation. Cell Rep. 2014;7(6):1796–808.

    Article  CAS  PubMed  Google Scholar 

  13. Paschall AV, Zimmerman MA, Torres CM, Yang D, Chen MR, Li X, et al. Ceramide targets xiap and ciap1 to sensitize metastatic colon and breast cancer cells to apoptosis induction to suppress tumor progression. BMC Cancer. 2014;14:24.

    Article  PubMed Central  PubMed  Google Scholar 

  14. Moreno-Martinez D, Nomdedeu M, Lara-Castillo MC, Etxabe A, Pratcorona M, Tesi N, et al. Xiap inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells. Oncotarget. 2014;5(12):4337–46.

    Article  PubMed Central  PubMed  Google Scholar 

  15. Shi Y. Mechanisms of caspase activation and inhibition during apoptosis. Mol Cell. 2002;9(3):459–70.

    Article  CAS  PubMed  Google Scholar 

  16. Li X, Huang T, Jiang G, Gong W, Qian H, Zou C. Synergistic apoptotic effect of crocin and cisplatin on osteosarcoma cells via caspase induced apoptosis. Toxicol Lett. 2013;221(3):197–204.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, Nanfang Hospital, Southern Medical University, No. 1838, North of Guangzhou Avenue, Baiyun District, Guangzhou, 510515, Guangdong Province, China

    X. Fu, X. Pang, H. Qi, S. Chen, Y. Li & W. Tan

  2. Department of Urology, Kaiping Central Hospital, Kaiping, 529300, China

    X. Fu

Authors
  1. X. Fu
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. X. Pang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. H. Qi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. S. Chen
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Y. Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W. Tan
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to W. Tan.

Ethics declarations

Conflict of interest

The authors have no conflict of interest to declare.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Fu, X., Pang, X., Qi, H. et al. XIAP inhibitor Embelin inhibits bladder cancer survival and invasion in vitro. Clin Transl Oncol 18, 277–282 (2016). https://doi.org/10.1007/s12094-015-1363-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12094-015-1363-2

Keywords

Search

Navigation